In addition, activation of the cGAS–STING pathway by cellular senescence may promote the induction of early age-related macular degeneration lesions (AMD), and thus this pathway may be a potential new target for the treatment of early AMD (Wu et al., 2019). The gene discussed is CGAS; the disease is age-related macular degeneration.